Barely Significant
← all excerpts

Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response.

Invest Ophthalmol Vis Sci · 2025 · PMC12697706 · PMID 41334961

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP < 0.0001actually significant
Quantification revealed a modest increase with MCM6 knockdown alone (significant in Y79, trending in WERI-Rb1), but the combination with melphalan induced a strong and highly significant increase in both cell lines ( P < 0.0001) ( Fig. 6 D).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.